Pre-Launch

Know where your
launch assumptions
could be wrong

Know what others can’t by connecting patient, prescriber, payer and clinical signals before assumptions become investments.

Before the first prescription is written, your team is already making decisions about where to invest, who to engage and how to enter the market.

Connect patient, prescriber, payer and clinical signals to test those assumptions against the market that exists today, not the one your launch plan assumes will exist tomorrow.

Discuss your use case

Book a 15 minute meeting to speak with an expert

HCP targeting

Legacy solutions vs HealthVerity

Reveal current HCP behavior Locate eligible patient opportunity Factor in payer + formulary reality

Legacy solutions prioritize markets using aggregate rankings and assumptions about similar therapies.

Estimated eligible patients

Legacy pick

HealthVerity pick

Legacy pick

launch markets

Why this decision matters

Launch is one of the largest single investments a program makes, and most of it gets committed before the first prescription is written. Field sizing, territory alignment, IC compensation design, MSL deployment and DTC media plans all get locked in 12-18 months ahead of launch. Every one of those decisions rests on assumptions about the market that only real prescriber and patient data can validate. Creating that picture with real prescriber and patient data is what turns a launch plan into an accurate one.

Know which types of decisions are enabled at this stage

Launch Strategy / Brand

Which HCPs and accounts represent the greatest opportunity - and why?

Commercial Analytics

Where are the patients we can actually reach, and does that match our planned territories?

Field Force Effectiveness

How do we size and align the team against real prescribing potential?

Medical Affairs

Where should MSLs focus, and which KOLs are actually treating these patients?

Market Access

Which payers, PBMs and formularies matter most in the first 12 months?

What a conventional pre-launch view may not show you

Historical prescribing, syndicated segmentation and analog brands can provide an important starting point. But they may not show whether the patients, HCPs, referral patterns and access dynamics in your launch assumptions actually align in the same places.

The question isn’t whether you have a launch plan. It’s what that plan might change if you could see more of the market before launch.

Diagram showing disconnected pre-launch inputs and assumptions

How our real-world data ecosystem helps you know what others can’t

Connect patient, HCP, treatment, geographic and payer signals to understand:

where diagnosed and treated patients are concentrated;
which HCPs are treating them and how those patients move through referral networks;
where clinical characteristics may change the addressable population;
how payer mix and access vary across the markets you plan to prioritize; and
where those signals reinforce — or challenge — your launch assumptions.

Diagram showing multiple connected signals informing pre-launch strategy

Bring us your question

Ready to pressure-test your launch plan?

Bring us the assumptions behind your launch strategy and we’ll help identify where connected patient, HCP, payer and clinical signals could sharpen the picture.

Pressure-test your launch plan

15-minute conversation with a HealthVerity expert

Know where yourlaunch assumptionscould be wrong